Home Healthcare Biotechnology Cell and Gene Therapy Market

Cell and Gene Therapy Market Size, Share & Trends Analysis Report By Type (Cell Therapy, CAR-T Cell Therapy, CAR-NK, B-Cell, Others, Viral, Non-viral), By Application (Oncology, Dermatology, Musculoskeletal, Immunology, Neurology, Others), By Manufacturer (Biopharmaceutical & Biotechnology Companies, Pharmaceutical Companies, CDMOs/CMOs, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 16, 2026 | Author: Debashree B | Format: | Report Code: SR2181DR | Pages: 180
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cell and Gene Therapy Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Cell Therapy
    2. CAR-T Cell Therapy
      1. Autologous CAR-T
      2. Allogeneic CAR-T
    3. CAR-NK
    4. B-Cell
    5. Others
      1. Gene Therapy
    6. Viral
      1. AAV
      2. Lentiviral vectors
      3. Others
    7. Non-viral
  2. Cell and Gene Therapy Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Dermatology
    3. Musculoskeletal
    4. Immunology
    5. Neurology
    6. Others
  3. Cell and Gene Therapy Market, By Manufacturer 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical & Biotechnology Companies
    2. Pharmaceutical Companies
    3. CDMOs/CMOs
    4. Others
  4. Regional Cell and Gene Therapy Market
    1. North America
      1. North America Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. CAR-T Cell Therapy
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        3. CAR-NK
        4. B-Cell
        5. Others
          1. Gene Therapy
        6. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        7. Non-viral
      2. North America Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Dermatology
        3. Musculoskeletal
        4. Immunology
        5. Neurology
        6. Others
      3. North America Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Biotechnology Companies
        2. Pharmaceutical Companies
        3. CDMOs/CMOs
        4. Others
      4. U.S. Cell and Gene Therapy Market
        1. U.S. Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. U.S. Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. U.S. Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      5. Canada Cell and Gene Therapy Market
        1. Canada Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Canada Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Canada Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
    2. Europe
      1. Europe Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. CAR-T Cell Therapy
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        3. CAR-NK
        4. B-Cell
        5. Others
          1. Gene Therapy
        6. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        7. Non-viral
      2. Europe Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Dermatology
        3. Musculoskeletal
        4. Immunology
        5. Neurology
        6. Others
      3. Europe Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Biotechnology Companies
        2. Pharmaceutical Companies
        3. CDMOs/CMOs
        4. Others
      4. U.K. Cell and Gene Therapy Market
        1. U.K. Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. U.K. Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. U.K. Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      5. Germany Cell and Gene Therapy Market
        1. Germany Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Germany Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Germany Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      6. France Cell and Gene Therapy Market
        1. France Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. France Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. France Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      7. Spain Cell and Gene Therapy Market
        1. Spain Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Spain Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Spain Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      8. Italy Cell and Gene Therapy Market
        1. Italy Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Italy Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Italy Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      9. Russia Cell and Gene Therapy Market
        1. Russia Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Russia Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Russia Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      10. Nordic Cell and Gene Therapy Market
        1. Nordic Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Nordic Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Nordic Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      11. Benelux Cell and Gene Therapy Market
        1. Benelux Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Benelux Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Benelux Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      12. Rest of Europe Cell and Gene Therapy Market
        1. Rest of Europe Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Rest of Europe Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Rest of Europe Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
    3. APAC
      1. APAC Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. CAR-T Cell Therapy
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        3. CAR-NK
        4. B-Cell
        5. Others
          1. Gene Therapy
        6. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        7. Non-viral
      2. APAC Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Dermatology
        3. Musculoskeletal
        4. Immunology
        5. Neurology
        6. Others
      3. APAC Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Biotechnology Companies
        2. Pharmaceutical Companies
        3. CDMOs/CMOs
        4. Others
      4. China Cell and Gene Therapy Market
        1. China Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. China Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. China Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      5. Korea Cell and Gene Therapy Market
        1. Korea Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Korea Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Korea Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      6. Japan Cell and Gene Therapy Market
        1. Japan Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Japan Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Japan Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      7. India Cell and Gene Therapy Market
        1. India Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. India Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. India Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      8. Australia Cell and Gene Therapy Market
        1. Australia Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Australia Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Australia Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      9. Taiwan Cell and Gene Therapy Market
        1. Taiwan Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Taiwan Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Taiwan Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      10. South East Asia Cell and Gene Therapy Market
        1. South East Asia Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. South East Asia Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. South East Asia Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      11. Rest of Asia-Pacific Cell and Gene Therapy Market
        1. Rest of Asia-Pacific Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Rest of Asia-Pacific Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Rest of Asia-Pacific Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
    4. Middle East and Africa
      1. Middle East and Africa Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. CAR-T Cell Therapy
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        3. CAR-NK
        4. B-Cell
        5. Others
          1. Gene Therapy
        6. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        7. Non-viral
      2. Middle East and Africa Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Dermatology
        3. Musculoskeletal
        4. Immunology
        5. Neurology
        6. Others
      3. Middle East and Africa Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Biotechnology Companies
        2. Pharmaceutical Companies
        3. CDMOs/CMOs
        4. Others
      4. UAE Cell and Gene Therapy Market
        1. UAE Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. UAE Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. UAE Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      5. Turkey Cell and Gene Therapy Market
        1. Turkey Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Turkey Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Turkey Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      6. Saudi Arabia Cell and Gene Therapy Market
        1. Saudi Arabia Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Saudi Arabia Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Saudi Arabia Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      7. South Africa Cell and Gene Therapy Market
        1. South Africa Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. South Africa Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. South Africa Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      8. Egypt Cell and Gene Therapy Market
        1. Egypt Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Egypt Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Egypt Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      9. Nigeria Cell and Gene Therapy Market
        1. Nigeria Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Nigeria Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Nigeria Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      10. Rest of MEA Cell and Gene Therapy Market
        1. Rest of MEA Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Rest of MEA Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Rest of MEA Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
    5. LATAM
      1. LATAM Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Cell Therapy
        2. CAR-T Cell Therapy
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        3. CAR-NK
        4. B-Cell
        5. Others
          1. Gene Therapy
        6. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        7. Non-viral
      2. LATAM Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Dermatology
        3. Musculoskeletal
        4. Immunology
        5. Neurology
        6. Others
      3. LATAM Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Biotechnology Companies
        2. Pharmaceutical Companies
        3. CDMOs/CMOs
        4. Others
      4. Brazil Cell and Gene Therapy Market
        1. Brazil Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Brazil Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Brazil Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      5. Mexico Cell and Gene Therapy Market
        1. Mexico Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Mexico Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Mexico Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      6. Argentina Cell and Gene Therapy Market
        1. Argentina Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Argentina Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Argentina Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      7. Chile Cell and Gene Therapy Market
        1. Chile Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Chile Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Chile Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      8. Colombia Cell and Gene Therapy Market
        1. Colombia Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Colombia Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Colombia Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
      9. Rest of LATAM Cell and Gene Therapy Market
        1. Rest of LATAM Cell and Gene Therapy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Cell Therapy
          2. CAR-T Cell Therapy
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          3. CAR-NK
          4. B-Cell
          5. Others
            1. Gene Therapy
          6. Viral
            1. AAV
            2. Lentiviral vectors
            3. Others
          7. Non-viral
        2. Rest of LATAM Cell and Gene Therapy Market By Application 2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Dermatology
          3. Musculoskeletal
          4. Immunology
          5. Neurology
          6. Others
        3. Rest of LATAM Cell and Gene Therapy Market By Manufacturer 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Biotechnology Companies
          2. Pharmaceutical Companies
          3. CDMOs/CMOs
          4. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.